Case File
efta-efta00480108DOJ Data Set 9OtherDS9 Document EFTA00480108
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00480108
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
To:
Subject:
Attachments:
>
Jefffrey Epstein [email protected]>
Fwd: Andra Info Submission to Jeffrey Epstein
Thu, 09 Aug 2018 22:26:12 +0000
Andra Fund - White_Paper_7.16.2018_vfinal.pdf: Andra_-
_
_ _
_Private_Placement_Offering_Memorandum_(Final).pdf;
Andra_Capitalinvestor_Deck_Final_8.8.2018.pdf; Andra_Capital_-
Modified Structure Chart 8-7a.pdf: Andra_GP_Purchase_Proforma 8.8.2018.xlsx
Sent from my iPhone
Begin forwarded message:
From: Paul Tuan
Date: Au ust 9, 2018 at 6:23:04 PM EDT
To:
Cc: Haydar Haba
Roman Glukhovsky
Subject: Andra Info Submission to Jeffrey Epstein
Hi MI
Thank you in advance for coordinating. Will you please forward this email to Jeffrey?
Hi Jeffrey,
Nice to meet you! Haydar really enjoyed meeting with you yesterday and speaks highly of you. He
asked that we provide you with some additional documentation regarding our innovation-impact
fund. I've attached our fund structure chart, PPM, white paper, and investor deck for your reference.
Andra Capital is a late-stage technology growth fund. Investors may participate in our fund through:
(i) direct traditional LP interest; or (ii) tokenized LP interest (blockchain smart contracts). Below are
some highlights of the fund:
• 30%+ target IRR returns, comparable with top-tier VCs
• Portfolio of the fastest growing technology pre-IPO companies
• World-class service providers include: lead counsel (DLA Piper); auditor (Deloitte);
compliance and valuation (Duff & Phelps); fund admin (Apex)
• News Releases: Business Wire Fortune Ledger Show Venture Beat Fintek Bitcoin Exchange
Our fund's innovative Silicon Valley Coin (SVC) provides liquidity on digital exchanges and access for
global investors:
• Ability to convert direct LP interest into SVCs
• Asset-backed, regulatory compliant, and tradable security token feature
EFTA00480108
• Option to cash out and realize investment returns without the typical waiting period of 8-12
years
I suggest that we schedule a call next week to discuss in detail once you've had a chance to review
the documents. Given your successful background in finance, we would be happy to offer you a GP-
purchase proposal for an opportunity to own an equity stake in our entire infrastructure. I've attached
the GP model demonstrating the economics for your review. I look forward to speaking to you.
Best,
Paul
Paul Tuan, Managing Director
Andra Ca ital
Andra Capital LLC accepts no liability for any errors or omissions arising at a result of this transmission. This message, including attachments, s intended only for the use of the
individual or entity to whom it is addressod,0 may contain information that is privileged, confidential
exempt from disclosure under applicable law !hew are not the
intended addressee, you must not use. copy disclose or take any action based on this message or any information heroin. If you received the message in error. please immediately
no* at Andra Capitol
its affiliates resrne the right to archive, monitor
review all email. This message does not constitute an offer to sell or a solicitation of an offer to
buy any semidry; Accordingly, no representation or warranty; expressed or otherwise. if made to,0no reliance should be placed on, the fairness. accuracy completeness or
timeliness of the information contained here.
EFTA00480109
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.